Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Nystatin Suspension on Oral Microbial Community
NCT04550546Phase 1Completed
- Sponsor
- University of Rochester
- Start
- May 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nystatin in oral candidiasis, sponsored by University of Rochester. Primary endpoint: Mean change in S. Mutans carriage at 3 months. Started May 2021; status: completed.
02
Drugs
nystatin
03
Conditions
oral candidiasis
Beyond the preview
Go deeper on NCT04550546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04550546.